Randomized, open-label, phase 2a study to evaluate the contribution of artefenomel to the clinical and parasiticidal activity of artefenomel plus ferroquine in African patients with uncomplicated Plasmodium falciparum malaria

DSpace Repositorium (Manakin basiert)

Randomized, open-label, phase 2a study to evaluate the contribution of artefenomel to the clinical and parasiticidal activity of artefenomel plus ferroquine in African patients with uncomplicated Plasmodium falciparum malaria

Autor(en): Gansane, Adama; Lingani, Moussa; Yeka, Adoke; Nahum, Alain; Bouyou-Akotet, Marielle; Mombo-Ngoma, Ghyslain; Kaguthi, Grace; Barcelo, Catalina; Laurijssens, Bart; Cantalloube, Cathy; Macintyre, Fiona; Djeriou, Elhadj; Jessel, Andreas; Bejuit, Raphael; Demarest, Helen; Marrast, Anne Claire; Debe, Siaka; Tinto, Halidou; Kibuuka, Afizi; Nahum, Diolinda; Mawili-Mboumba, Denise Patricia; Zoleko-Manego, Rella; Mugenya, Irene; Olewe, Frederick; Duparc, Stephan; Ogutu, Bernhards
Tübinger Autor(en):
Mombo-Ngoma, Ghyslain
Zoleko-Manego, Rella
Erschienen in: Malaria Journal (2023), Bd. 22 (1), Article 2
Verlagsangabe: Bmc
Sprache: Englisch
Referenz zum Volltext: http://dx.doi.org/10.1186/s12936-022-04420-2
ISSN: 1475-2875
DDC-Klassifikation: 570 - Biowissenschaften, Biologie
610 - Medizin, Gesundheit
Dokumentart: Wissenschaftlicher Artikel
Zur Langanzeige

Das Dokument erscheint in: